Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: Are they useful?

Modern Pathology

Volumn 10, Issue 6, 1997, Pages 572-577

  Mori, Masuko ^a   Kohli, Anupama ^a   Baker, Stephen P ^a   Savas, Lou ^a   Fraire, Armando E ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Cathepsin B; Immunohistochemistry; Laminin; Lung; Non small cell carcinoma; Prognosis

Indexed keywords

CATHEPSIN B; LAMININ;

ARTICLE; BASEMENT MEMBRANE; CANCER STAGING; EXTRACELLULAR MATRIX; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN METABOLISM; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CATHEPSIN B; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0030831308     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mountain CF, Greenberg SD, Fraire AE. Tumor stage in non-small cell carcinoma of lung. Chest 1991;99:1258-60.
2. Dressier CM, Ritter JH, Wick MR, Roper CL, Patterson GA, Cooper JD. Immunostains for blood group antigens lack prognostic significance in T1 lung carcinoma. Annu Thorac Surg 1995;59:1069-73.
3. Greenberg SD, Fraire AE, Kinner BM, Johnson EH. Prognosis in carcinoma of the lung. Tumor cell type versus staging. In: Rosen PP, Fechner RE, editors. Pathology annual, Norwalk, CT: Appleton Lange, 1987:387-405.
4. Churg A. Tumors of the lung. In: Thurlbeck WM, editor. Pathology of the lung. New York: Thieme, 1988:311-423.
5. Wetzels RHW, Schaafsma HE, Leigh IM, Lane EB, Troyanovsky SM, Wagenaar SSC, et al. Laminin and type VII collagen distribution in different types of human lung carcinoma: correlation with expression of keratins 14, 16, 17, and 18. Histopathology 1992;20:295-303.
6. Sukoh N, Abe S, Nakajima I, Ogura S, Isobe H, Inoue K, et al. Immunohistochemical distributions of cathepsin B and basement membrane antigens in human lung adenocarcinoma: association with invasion and metastasis. Virch Arch 1994;424:33-8.
7. Sukoh N, Abe S, Ogura S, Isobe H, Takekawa H, Inoue K, et al. Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer. Cancer 1994;74:46-51.
8. Ozeki Y, Takishima K, Takagi K, Aida S, Tamai S, Mamiya G, et al. Immunohistochemical analysis of cathepsin B expression in human lung adenocarcinoma: the role in cancer progression. Jpn J Cancer Res 1993;84:972-5.
9. Inoue T, Ishida T, Sugio K, Sugimachi K. Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma. Cancer Res 1994;54:6133-6.
10. Sloane BF, Bajkawaki AS, Day NA, Honn KV, Crissman JD. Purification and properties of a cathepsin B-like enzyme from human tumors: comparison with cathepsin B isolated from human liver spleen. Proc Am Assoc Cancer Res (A) 1984;25:4.
11. Sloane BF, Moin K, Krepela E, Rozhin J. Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Cancer Metastasis Rev 1990;9:333-52.
12. Matsui K, Kitagawa M, Sugiyama S, Yamamoto K. Distribution pattern of the basement membrane components is one of the significant prognostic correlates in peripheral lung adenocarcinomas. Hum Pathol 1995;26:186-94.
13. Cox DR. Regression models and life tables. J Royal Statistic Soc Series B 1972;34:187-220.
14. Tarone RE, Ware J. On distribution-free Tests for equality of survival distribution. Biometrika 1977;64:156-60.
15. Lee ET. Statistical methods for survival data analysis. New York: Wiley, 1992:36-8.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statistic Assoc 1958;53:457-81.
17. Freeman GA, Halton IA. Note on an exact treatment of contingency, goodness of fit, and other problems of significance. Biometrika 1951;38:141-9.
18. Liotta LA. Tumor invasion and metastases: role of the extra-cellular matrix. Cancer Res 1986;46:1-7.
19. Nishino T, Ishida T, Oka T, Yasumoto K, Sugimachi K. Prognostic significance of laminin in adenocarcinoma of lung. J Surg Oncol 1990;43:214-8.
20. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980;284:67-8.
21. Campo E, Muñoz J, Miquel R, Palacin A, Cardesa A, Sloane BF, et al. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Path 1994;145:301-9.
22. Lah TT, Kokalj-Kunovar M. Štrukelj B, Pungerčar J. Barlič-Maganja D, Drobnič-Košorok M. et al. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int J Cancer 1992;50:36-44.
23. Castiglioni T, Merino MJ, Elsner B, Lah TT, Sloane BF, Emmert-Buck MR. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Hum Pathol 1994; 25:857-62.
24. Hida J, Matsuda T, Kitaoka M, Machidera N, Kubo R, Yasutomi M. The role of basement membrane in colorectal cancer invasion and liver metastasis. Cancer 1994;74:592-8.
25. Schor SL. Cell proliferation and migration on collagen substrata in vitro. J Cell Sci 1980;41:159-75.
26. Sas DF, McCarthy JB, Furcht LT. Clearing and release of basement membrane proteins from substrates by metastatic tumor cell variants. Cancer Res 1986;46:3082-9.
27. Irimura T, Yamori T, Bennett SC, Ota DM, Cleary KR. The relationship of collagenolytic activity to stage of human colorectal carcinoma. Int J Cancer 1987;40:24-31.